Copyright © 2013 Knight Sac Media. All rights reserved.http://www.siliconinvestor.com/subject.aspx?subjectid=55389Website: clinuvel.com  Australian Exchange: finance.yahoo.com  ADR: finance.yahoo.com  pinksheets.com quote: pinksheets.com  aktienkurs-orderbuch.finanznachrichten.de  Australian Message Board: sharescene.com  Corporate Profile Clinuvel Pharmaceuticals Limited (formerly Epitan Limited) is...http://www.siliconinvestor.com/images/Logo380x132.pnghttp://www.siliconinvestor.com/subject.aspx?subjectid=5538938013210caly Clinuvel commences US Phase III trial of SCENESSE® in rare light and UV disorder clinuvel.com http://www.siliconinvestor.com/readmsg.aspx?msgid=281609725/22/2012 7:14:22 AMcaly Clinuvel, FDA agree in principle to Phase III study with SCENESSE® (afamelanotide) SCENESSE® (afamelanotide 16mg) to be trialled for rare disease in US Phase IIIMelbourne, Australia and Baar, Switzerland, March 15 201 Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) today announced that it ...http://www.siliconinvestor.com/readmsg.aspx?msgid=280137103/15/2012 9:02:05 AMcaly Clinuvel demonstrates positive treatment effect of afamelanotide in US Phase II study clinuvel.com http://www.siliconinvestor.com/readmsg.aspx?msgid=2774365611/3/2011 8:55:19 AM